The related mechanisms may involve an inhibitory effect on the IL-6/LIF system, promoting the release of ligands of the CXCR3 receptor, chemokines CXCL9 and CXCL10 (IP-9), which chemoattract several types of immune cells that infiltrate a tumor and prevent its growth. Here, CXCL9 is linked to neoplasm.